The "CLL Panel Cytogenetics and FISH del11q Trisomy 12 del13q del17p Test" is a specialized diagnostic procedure aimed at patients with Chronic Lymphocytic Leukemia (CLL), one of the most common types of leukemia in adults. This comprehensive test combines cytogenetic analysis and Fluorescence In Situ Hybridization (FISH) to detect specific genetic abnormalities associated with CLL, namely deletions in chromosomes 11q, 13q, 17p, and trisomy of chromosome 12.
Cytogenetics involves examining the chromosomes in cells to identify structural changes that may lead to disease, while FISH is a more targeted approach that uses fluorescent probes to visualize specific DNA sequences on chromosomes. Together, these methodologies offer a powerful tool for the precise identification of genetic markers critical for prognosis and treatment planning in CLL patients.
The test, which costs 3600 AED, is conducted at DNA Labs UAE, a facility known for its advanced diagnostic capabilities and expertise in genetic testing. The results from this panel are pivotal for clinicians in tailoring treatment strategies, predicting disease progression, and ultimately improving patient outcomes.
The Hepatitis C Virus (HCV) Qualitative PCR and HCV Genotyping Combo Test is a comprehensive diagnostic assessment offered by DNA Labs UAE, designed to detect and characterize the hepatitis C virus in an individual's blood. Priced at 3600 AED, this advanced testing combination serves two primary functions:
1. **HCV Qualitative PCR:** This part of the test utilizes the Polymerase Chain Reaction (PCR) technique to detect the presence of HCV RNA in the blood, determining whether an individual is currently infected with the hepatitis C virus. It is highly sensitive and can identify the virus even in low quantities, making it an effective tool for early detection.
2. **HCV Genotyping:** Upon confirming the presence of HCV, the test proceeds to identify the specific genotype of the virus. HCV has several genotypes and subtypes, and identifying them is crucial because the virus's genotype significantly influences treatment decisions, durations, and potential outcomes. Certain medications may be more effective against specific genotypes, making this information vital for devising an effective treatment plan.
The combination of these tests at DNA Labs UAE offers a thorough diagnostic approach, providing essential information for the management and treatment of hepatitis C. The test cost of 3600 AED reflects the comprehensive nature of the assessment, leveraging cutting-edge technology to ensure accuracy and reliability in results. Patients seeking this test can expect a detailed analysis, aiding healthcare providers in making informed decisions tailored to the individual's specific healthcare needs.
The KRAS/NRAS test is a specialized diagnostic procedure designed to identify mutations in the KRAS and NRAS genes, which are known to play a significant role in the development and progression of certain types of cancers, including colorectal and lung cancers. This test is crucial for determining the most effective treatment plan for patients, as the presence of mutations can influence the response to targeted therapies.
Performed at DNA Labs UAE, a leading facility in genetic testing, the KRAS/NRAS test utilizes advanced molecular techniques to accurately detect these genetic alterations. The cost of the test is set at 3600 AED, reflecting the comprehensive analysis and the technical expertise required to interpret the results.
By identifying specific mutations in the KRAS and NRAS genes, healthcare providers can tailor cancer treatment to the individual patient, improving outcomes and minimizing unnecessary treatments. This test represents a significant step forward in the field of personalized medicine, offering hope for more effective and targeted cancer therapies.
Liquid biopsy is a cutting-edge, non-invasive medical test that offers a revolutionary approach to cancer diagnostics and monitoring. Unlike traditional biopsy methods that require surgical procedures to collect tissue samples, liquid biopsy examines cancer-related information through a simple blood sample. This innovative method detects and analyzes fragments of tumor DNA (ctDNA) that are freely circulating in the bloodstream, providing valuable insights into the genetic mutations associated with cancer.
One specific application of liquid biopsy is the Cell-Free BRAF Test. This test is designed to identify mutations in the BRAF gene, which are commonly associated with various cancers, including melanoma, colorectal cancer, and thyroid cancer. The presence of these mutations can help in determining the prognosis of the disease and in selecting targeted therapies that improve treatment outcomes.
Conducted at DNA Labs UAE, the Cell-Free BRAF Test is a prime example of the advancements in personalized medicine. By offering a less invasive, more convenient option for patients, it significantly reduces the discomfort and risks associated with traditional biopsy methods. Moreover, it allows for real-time monitoring of tumor dynamics and the effectiveness of treatment, enabling timely adjustments to the therapeutic strategy.
The cost of the Cell-Free BRAF Test at DNA Labs UAE is 3600 AED. While this price may seem significant, the value it provides in terms of accurate diagnosis, personalized treatment planning, and non-invasiveness makes it a worthwhile investment in the management of cancer.
Liquid Biopsy: Cell-Free KRAS Test
The Liquid Biopsy: Cell-Free KRAS Test is a cutting-edge diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the KRAS gene without the need for invasive surgical biopsies. Utilizing a simple blood sample, this test isolates and analyzes cell-free DNA (cfDNA) circulating in the bloodstream, which can shed light on the genetic makeup of cancer cells.
KRAS mutations are pivotal in the development and progression of various cancers, including colorectal, lung, and pancreatic cancers. Early and accurate detection of these mutations can significantly impact treatment decisions and patient outcomes, offering a personalized approach to cancer therapy.
Priced at 3600 AED, the Cell-Free KRAS Test at DNA Labs UAE represents a significant advancement in non-invasive cancer diagnostics, providing patients and healthcare providers with crucial genetic information swiftly and safely, without the discomfort and complications associated with traditional biopsy methods.
The "Lung Cancer Panel 1 EGFR ALK1 Test" is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify specific genetic mutations within the EGFR (Epidermal Growth Factor Receptor) and ALK1 (Anaplastic Lymphoma Kinase) genes. These mutations are significant markers for non-small cell lung cancer (NSCLC), which is the most common type of lung cancer. Identifying the presence of these mutations can greatly influence the treatment approach, enabling healthcare providers to tailor targeted therapies that are more effective and have fewer side effects compared to conventional treatments.
The test is priced at 3600 AED and involves analyzing a patient's DNA sample, typically obtained through a biopsy or a blood sample, to detect the presence of these genetic alterations. By pinpointing the exact nature of the mutation, the test not only helps in confirming a diagnosis of lung cancer but also in predicting the patient's response to specific targeted therapies, thus playing a crucial role in personalized medicine.
DNA Labs UAE is known for its advanced diagnostic technologies and expertise in genetic testing, ensuring that the Lung Cancer Panel 1 EGFR ALK1 Test is conducted with high precision and reliability. The results from this test can provide valuable insights for oncologists, helping them to devise a more effective and customized treatment plan for their patients with NSCLC.
The "Microarray 315K and Single Karyotyping AFCVSCBPOCPB Test" is a comprehensive genetic analysis procedure available at DNA Labs UAE. This advanced diagnostic tool combines the power of microarray technology, which examines 315,000 specific markers across the genome, with single karyotyping to provide a detailed view of an individual's genetic makeup. This dual approach allows for the detection of various genetic disorders, chromosomal abnormalities, and potential predispositions to certain diseases by analyzing both the broad genetic landscape and the specific structure of individual chromosomes.
The test is particularly useful for couples planning a pregnancy, individuals with a family history of genetic disorders, or anyone interested in gaining a deeper understanding of their genetic health. The cost of the test is 3600 AED, reflecting the comprehensive nature of the analysis and the detailed insights it provides.
DNA Labs UAE, where this test is conducted, is known for its state-of-the-art facilities and commitment to providing accurate, reliable genetic testing services. The lab employs a team of highly skilled professionals who ensure that each test is conducted with the utmost precision and care, making it a trusted choice for genetic diagnostics in the region.
The "Microarray 60K POC and Couple Karyotyping Test" offered by DNA Labs UAE is a comprehensive genetic testing package designed for couples planning to conceive or experiencing challenges with fertility. This advanced diagnostic tool combines the power of microarray analysis with karyotyping to provide a detailed understanding of the genetic factors that could affect pregnancy outcomes.
Microarray 60K POC (Products of Conception) analysis is a high-resolution test that examines fetal tissue for genetic abnormalities, such as chromosomal deletions or duplications, which could be responsible for miscarriages or fetal abnormalities. This component of the test helps in identifying potential genetic reasons behind recurrent pregnancy loss, enabling healthcare providers to offer targeted interventions or counseling.
Couple Karyotyping is a complementary test that analyzes the chromosomes of both partners to detect any structural or numerical chromosomal abnormalities that could impair fertility or lead to recurrent miscarriages. This analysis is crucial for identifying risks of passing on genetic conditions to offspring, thereby assisting in making informed reproductive decisions.
Performed at the state-of-the-art facilities of DNA Labs UAE, this combined testing package is priced at 3600 AED. It represents a valuable investment for couples seeking in-depth insights into their genetic makeup and its implications on fertility and pregnancy. By identifying specific genetic issues, the test empowers couples and their healthcare providers with the knowledge needed to address fertility challenges more effectively, enhancing the chances of a successful pregnancy.
The "MM Panel Cytogenetics and FISH del11q del13q IgH del17p Test" is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect specific chromosomal abnormalities associated with multiple myeloma, a type of blood cancer. This test employs cytogenetic and Fluorescence In Situ Hybridization (FISH) techniques to identify deletions in chromosomes 11q, 13q, and 17p, as well as changes in the immunoglobulin heavy chain (IgH) gene. These genetic markers are crucial for diagnosing multiple myeloma, predicting disease progression, and tailoring personalized treatment plans for patients. The test is priced at 3600 AED, reflecting the sophisticated technology and expertise required to accurately detect these genetic abnormalities. By offering this test, DNA Labs UAE provides essential support for the effective management of multiple myeloma, helping to improve patient outcomes through targeted therapy and monitoring.
Prenatal diagnostic screening through Karyotyping and Fluorescence In Situ Hybridization (FISH) is a crucial medical procedure offered by DNA Labs UAE, aimed at detecting chromosomal abnormalities in fetuses. This test specifically focuses on chromosomes 13, 18, 21, X, and Y, which are commonly associated with genetic disorders such as Down syndrome (Trisomy 21), Patau syndrome (Trisomy 13), Edwards syndrome (Trisomy 18), and abnormalities related to the sex chromosomes. The combination of karyotyping and FISH provides a comprehensive analysis, with karyotyping offering a broad view of all chromosomes, and FISH providing a more targeted approach for specific chromosomes of interest.
The test is priced at 3600 AED and is conducted in the advanced facilities of DNA Labs UAE, which is equipped with state-of-the-art technology and staffed by experienced geneticists and laboratory technicians. This prenatal screening is crucial for expectant parents looking for early diagnosis of potential genetic conditions, allowing for informed decisions regarding pregnancy management and preparation for any needed medical interventions post-birth.
